Skip to main content

Bevespi Aerosphere News

Bevespi Aerosphere Approved by the FDA for Patients with COPD

25 April 2016 – AstraZeneca today announced that the US Food and Drug Administration has approved Bevespi Aerosphere (glycopyrrolate and formoterol fumarate) inhalation aerosol indicated for the...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Chronic Obstructive Pulmonary Disease

Bevespi Aerosphere patient information at Drugs.com